− Phase 3b Open-Label Study Showed Treatment with Patisiran Achieved Rapid and Sustained Reduction in Serum TTR Levels in hATTR Amyloidosis Patients with Polyneuropathy Progression Following Orthotopic Liver Transplant – − Additional Results from Pre-specified Patient Subgroups Analysis Included with Encore Presentation of HELIOS-A Phase 3 Study of Investigational Vutrisiran […]
Other News
Heart-Valve-Surgery.com Launches “Clinical Trials Education Platform” to Educate & Empower Heart Valve Patients
TORRANCE, Calif., June 4, 2021 /PRNewswire/ — Heart-Valve-Surgery.com, a leading patient advocacy group for patients with heart valve disease, today launched the first phase of an end-to-end digital platform for patient awareness, patient education and patient enrollment specific to clinical trials. The new platform – which leverages novel algorithms and technologies – was […]
Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation
SUZHOU, China, June 4, 2021 /PRNewswire/ — Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality […]
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
Vancouver, BC, Canada, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 3, 2021 in Vancouver, B.C. (the “Meeting”). At the Meeting, […]
Abbott Confirms Capacity to Support Expanded Use of HeartMate 3™ Heart Pump
– Abbott has the capacity and supply to support increased demand for mechanical circulatory support (MCS) devices following Medtronic’s decision to stop the global distribution and sale of the Medtronic HeartWare™ ventricular assist device (HVAD) – Access to MCS devices are critical for advanced heart failure patients and can improve […]
Medtronic to Stop Distribution and Sale of HVAD™ System
– Company Developing Support Program for Current HVAD Patients – Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, is stopping the distribution and sale of the Medtronic HVAD™ System. This morning, the […]
Ionis announces changes to its board of directors at annual meeting of stockholders
– Joseph Loscalzo, M.D., Ph.D., appointed chairman of the board – Ionis founder and Executive Chairman Stanley T. Crooke, M.D., Ph.D., retires from the board – Breaux B. Castleman retires from the board – Allene M. Diaz appointed to the board CARLSBAD, Calif., June 2, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today […]
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application ANAVEX®2-73 (blarcamesine) for the Treatment of Cardiac Dysfunctions
Issuance of Its Newest U.S. Patent Will Strengthen Anavex’s Compounds Intellectual Property Portfolio NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s […]
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
Results show that first-of-its-kind device has a sustained treatment effect and a positive impact on quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips […]
GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care
CHICAGO–(BUSINESS WIRE)–GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes. The Consortium […]



